NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T ...

Large Granular Lymphocyte Leukemia (LGLL) is a rare, chronic lymphoproliferative disorder primarily defined by the clonal expansion of cytotoxic T cells or natural killer (NK) cells. Clinically, the ...

NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells, ...

A phase I/II trial of combination of PKC412 and 5-azacytidine (AZA) for the treatment of patients with refractory or relapsed (R/R) acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Abcuro to Present Interim Phase 1 Data Evaluating Ulviprubart in Patients with T Cell Large Granular Lymphocytic Leukemia at the 67th American Society of Hematology Annual Meeting Abcuro, Inc., a late ...

(WNDU) - Large granular lymphocytic (LGL) leukemia is a type of chronic leukemia that affects white blood cells called “lymphocytes.” “LGL stands for what the cells look like,” explained Thomas P.

About 15% of cases of large granular lymphocytic leukemia involve natural killer cells. New research may make it easier for clinicians to confirm clonality of natural killer (NK) cells, ultimately ...

An anthropometric study in children with chronic myeloid leukemia on imatinib. Maintenance therapy with arsenic after induction in an alternative and long-term case for the prevention of recurrence of ...

An international study coordinated by a University of Helsinki research group demonstrates that the body's immune system attacks itself in a rare type of blood cancer. Consequently, treatment should ...